BORTENAT 2mg Vial contains the active substance Bortezomib. It belongs to a group of medicines known as Proteasome Inhibitors. It is primarily indicated for the treatment of Multiple Myeloma and Mantle Cell Lymphoma (MCL). Bortezomib works by interfering with the protein degradation process inside cancer cells, leading to their death and helping slow disease progression.
BORTENAT 2mg Vial is administered by a qualified healthcare professional and should only be used under the supervision of an oncologist experienced in cancer treatment.
Uses of BORTENAT 2mg Vial
- Treatment of Multiple Myeloma
- Treatment of Mantle Cell Lymphoma (MCL)
- Relapsed or Refractory Multiple Myeloma
- Combination chemotherapy regimens
- Management of specific hematological malignancies
Therapeutic Effects of BORTENAT 2mg Vial
BORTENAT 2mg Vial works by inhibiting proteasomes, which are cellular structures responsible for breaking down unwanted proteins. By blocking this process, Bortezomib causes the accumulation of abnormal proteins within cancer cells, leading to cell stress, apoptosis (cell death), and inhibition of tumor growth.
Interaction of BORTENAT 2mg Vial with Other Drugs
It is important to inform your healthcare professional about all medications you are taking, including prescription medicines, supplements, and herbal products.
Notable interactions include:
-
Ketoconazole: May increase Bortezomib blood levels.
-
Rifampicin: May reduce the effectiveness of Bortezomib.
-
Phenytoin: May affect treatment response.
-
Carbamazepine: May decrease drug effectiveness.
-
Antidiabetic Medicines: Blood sugar monitoring may be required.
-
Other Chemotherapy Agents: Increased risk of side effects and toxicity.
More Information about BORTENAT 2mg Vial
- Keep out of reach of children.
- Store below 25°C in a cool and dry place.
- Protect from direct sunlight.
- Do not freeze.
- Use only under medical supervision.
How to Consume BORTENAT 2mg Vial
BORTENAT 2mg Vial is administered as an intravenous (IV) or subcutaneous (SC) injection by a healthcare professional.
The dosage and treatment schedule are determined by your oncologist based on your body weight, medical condition, and treatment response. Do not self-administer this medicine.
Safety Advice for BORTENAT 2mg Vial
Breast Feeding
Unsafe / Contraindicated
Breastfeeding should be avoided during treatment as Bortezomib may harm the nursing infant.
Alcohol
Caution
Alcohol may worsen side effects such as dizziness, fatigue, and nerve-related symptoms.
Liver
Caution
Patients with liver impairment may require dose adjustments and close monitoring.
Kidneys
Caution
Use under medical supervision in patients with kidney disease.
Driving
Caution
BORTENAT may cause dizziness, fatigue, fainting, or blurred vision. Avoid driving if affected.
Pregnancy
Unsafe / Contraindicated
Bortezomib can cause serious fetal harm. Effective contraception should be used during treatment.
Side Effects of BORTENAT 2mg Vial
Side effects are unwanted symptoms caused by medicines. Although not everyone experiences them, some patients may develop side effects.
Common Side Effects of BORTENAT 2mg Vial
- Fatigue
- Nausea and vomiting
- Diarrhea
- Constipation
- Fever
- Loss of appetite
- Weakness
Serious Side Effects of BORTENAT 2mg Vial
- Peripheral neuropathy (numbness and tingling in hands and feet)
- Severe infections
- Low platelet count (thrombocytopenia)
- Low white blood cell count
- Heart-related complications
- Severe liver problems
- Tumor lysis syndrome
Word of Advice
Regular blood tests are essential during treatment with BORTENAT 2mg Vial to monitor blood cell counts, liver function, and kidney function. Report symptoms such as numbness, tingling, unusual bleeding, severe fatigue, shortness of breath, or signs of infection immediately. Maintaining adequate hydration and following your oncologist's treatment schedule can help optimize treatment outcomes.
FAQs about BORTENAT 2mg Vial
Q1. What is BORTENAT 2mg Vial used for?
It is used for the treatment of Multiple Myeloma and Mantle Cell Lymphoma.
Q2. How does BORTENAT work?
It blocks proteasomes inside cancer cells, causing the accumulation of abnormal proteins and leading to cancer cell death.
Q3. Can BORTENAT cause nerve damage?
Yes. Peripheral neuropathy is a known side effect and may cause numbness, tingling, or pain in the hands and feet.
Q4. Why are regular blood tests required?
Blood tests help monitor blood counts and detect potential treatment-related complications early.
Q5. Can BORTENAT increase infection risk?
Yes. The medicine may lower white blood cell counts, making infections more likely. Seek medical attention if you develop fever or signs of infection.
Fact Box of BORTENAT 2mg Vial
Molecule Name: Bortezomib 2mg
Therapeutic Class: Antineoplastic Agents
Pharmacological Class: Proteasome Inhibitors
Indications: Multiple Myeloma, Mantle Cell Lymphoma (MCL), Relapsed Hematological Malignancies, Combination Cancer Therapy.
